DBV Technologies S.A. Statistics
NASDAQ: DBVTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
9.02-0.40 (-4.25%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
DBV Technologies S.A. by the numbers
DBV Technologies S.A. has a market capitalization of $566.8 million based on 62.84M shares outstanding. With trailing EPS of $-3.00, DBV Technologies S.A. is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.1% below its 50-day average and 43.8% below its 200-day average.
Average daily trading volume is 352.88K shares, or about $3.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
DBVT valuation vs. peer median
| Metric | DBVT | Peer median | Difference |
|---|---|---|---|
| Market cap | $566.82M | $576.14M | -2% |
| Avg. volume | 352.88K | 637.10K | -45% |
Peer median across 8 companies: ENTX, FDMT, CGEM, SRZN, IAM, ETRA, VALN, DNA.
Valuation
- Market cap
- $566.82M
- Price / sales (latest FY)
- 100.57
- EPS (TTM)
- $-3.00
- Shares outstanding
- 62.84M
Price and trading
- Previous close
- 9.42
- Open
- 9.43
- Day range
- 9.00 – 9.47
- 52-week range
- 8.63 – 26.19
- 52-week change
- -34.40%
- Beta
- —
- Volume
- 156.50K
- Average volume
- 352.88K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 28, 2026
Additional statistics
- Market Cap
- 566.82M
- Forward Pe
- -23.23
- Eps
- -3.00
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 26.19
- Week52 Low
- 8.63
- Avg Volume
- 352.88K
- Shares Outstanding
- 62.84M
- Ma50
- 10.51
- Ma200
- 16.05
- Earnings Date
- Oct 28, 2026
- Pct From52w High
- -65.55%
- Pct From52w Low
- 4.52%